RecBio

Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
RecBio is a research and development company of genetic engineering vaccine for major diseases, which is committed to the innovation and industrialization of genetic engineering vaccine for major diseases, and has an innovative research and development technology platform for protein engineering and new adjuvant technology. At present, RuiKeShengWu has several product lines with market capacity of tens of billions represented by HPV series vaccines, recombinant herpes zoster virus vaccines, tuberculosis vaccines and recombinant COVID-19 vaccines, which are in different research and development stages

Transactions

Funding 1 Fundings

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 0 Competitors